Fri, Dec 19, 2014, 9:59 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • g_dargusch g_dargusch Apr 3, 2014 8:27 AM Flag

    OH BOY ANOTHER PHASE APPROVAL,,,LUXEMBOURG,,, BUT STILL NO

    LAUNCH

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • April 3, 2014
      08:06 EDT APRI, NVS Apricus Biosciences granted national phase approval for Vitaros in Luxembourg
      Apricus Biosciences (APRI) announced that the Ministry of Health of Luxembourg has granted national phase approval to Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction. The company has now received a total of nine national phase approvals for Vitaros®, including Luxembourg, Belgium, France, Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom following its broad approval by European health authorities in June 2013. Apricus has an exclusive commercialization partnership in place with Hexal AG, an affiliate within the Sandoz Division of the Novartis (NVS), for the commercialization of Vitaros in several European countries, including Luxembourg. THANKS TO "THE FLY"

 
APRI
0.95-0.0480(-4.81%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.